Insider trades
Phillip Pang, Chief Officer of Vir Biotechnology VIR, has filed 0 purchases and 8 sales on the open market. The latest trade was on 24/02/22.
Phillip Pang
EVP & Chief Medical Officer
- Company
- Vir Biotechnology VIR
- First filing
- 23/01/25
- Trades
- 22 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- No record
- Last trade
- 24/02/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 24/02/22 | 24/02/26 | 14,568 sh | $10.05 | $146,408.4 | −5.5% | |
| Open-market sale10b5-1 plan | 24/02/16 | 24/02/16 | 3,321 sh | $10.24 | $34,007.04 | −1.2% | |
| Open-market sale10b5-1 plan | 23/06/07 | 23/06/08 | 5,000 sh | $25.95 | $129,750 | −2.6% | |
VIR | Open-market sale | 23/02/27 | 23/02/28 | 10,320 sh2 trades | $23.08avg. | $238,144 | −5.2% |
| Open-market sale | 23/02/23 | 23/02/24 | 2,878 sh | $25.97 | $74,741.66 | −1.4% | |
| Open-market sale | 23/02/17 | 23/02/21 | 2,802 sh | $25.29 | $70,862.58 | −1.9% | |
| Open-market sale | 23/01/24 | 23/01/25 | 30,000 sh | $30.00 | $900,000 | −17.2% |